Get the Stockscreener App
69.96
1.23%
-0.873
Invesco Biotechnology Genome Etf stock is traded at $69.96, with a volume of 988.
It is down -1.23% in the last 24 hours and up +1.18% over the past month.
See More
Previous Close:
$70.83
Open:
$70.32
24h Volume:
988
Relative Volume:
0.15
Market Cap:
$281.93M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.44%
1M Performance:
+1.18%
6M Performance:
+9.55%
1Y Performance:
+17.09%
1-Day Range:
$70.13
$70.32
1-Week Range:
$70.13
$70.83
52-Week Range:
$59.32
$72.84
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Name
Invesco Biotechnology Genome Etf
Sector
Industry
Phone
-
Address
-
Compare PBE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
70.14 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
299.99 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
602.94 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
605.92 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
259.06 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
515.09 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf Stock (PBE) Latest News
Trading (PBE) With Integrated Risk Controls - Stock Traders Daily
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - MSN
Wolfe Research Initiates Coverage of Repligen (RGEN) with Peer Perform Recommendation - MSN
Is Bioceres Crop Solutions (BIOX) The Best Agriculture Stock To Buy Right Now? - MSN
How Should You Play Medifast Stock at a P/E Multiple of 17.6X? - MSN
Evolve European Banks Enhanced Yield ETF declares CAD 0.145 dividend - MSN
Is Bunge Global SA (BG) the Best Fertilizer Stock to Buy? - MSN
Scotiabank Initiates Coverage of Veeva Systems (VEEV) with Sector Perform Recommendation - MSN
Healthpeak Properties Getting Closer To Key Technical Measure - MSN
Pacific Smiles Weighs Final Takeover Offer from Genesis - MSN
Sino Biopharmaceutical’s Strategic Investment in Biotech - MSN
Morphic Ethical Equities Fund Optimizes Capital Structure - MSN
Ping An Healthcare Offers Special Dividend Amidst Takeover Talks - MSN
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - MSN
Invesco BulletShares 2032 Municipal Bond ETF declares monthly distribution of $0.0761 - MSN
IDEX Biometrics Expands with Cellfie Global Partnership - MSN
Big Technologies PLC Boosts Value with Share Buyback - MSN
Hemogenyx Pharmaceuticals Secures Funding for Clinical Trials - MSN
(PBE) Technical Data - Stock Traders Daily
(PBE) Trading Report - Stock Traders Daily
(PBE) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record - MSN
Down 57% in 2024, Is Recursion Pharmaceuticals a Buy on the Dip? - MSN
Tealwood Asset Management Inc. Has $2.43 Million Stake in McDonald’s Co. (NYSE:MCD) - Defense World
Marshall Wace LLP Reduces Stock Position in SelectQuote, Inc. (NYSE:SLQT) - Defense World
Tealwood Asset Management Inc. Acquires New Shares in The Charles Schwab Co. (NYSE:SCHW) - Defense World
(PBE) Investment Analysis - Stock Traders Daily
Marshall Wace LLP Acquires 87,283 Shares of KNOT Offshore Partners LP (NYSE:KNOP) - Defense World
Marshall Wace LLP Acquires 3,483 Shares of Global X MLP & Energy Infrastructure ETF (NYSEARCA:MLPX) - Defense World
ProShare Advisors LLC Has $55,000 Stake in Sharecare, Inc. (NASDAQ:SHCR) - Defense World
Is Iovance Biotherapeutics Stock a Buy? - MSN
7 Best-Performing Biotech ETFs for November 2024 - NerdWallet
IBBQ: This Low-Cost Biotech ETF Comes With Unique Risks (NASDAQ:IBBQ) - Seeking Alpha
BioMarin Pharmaceutical (NASDAQ:BMRN) Given New $87.00 Price Target at Stifel Nicolaus - Defense World
Arizona State Retirement System Acquires 32,217 Shares of Plug Power Inc. (NASDAQ:PLUG) - Defense World
Ashton Thomas Private Wealth LLC Makes New Investment in Innovator U.S. Equity Ultra Buffer ETF – April (BATS:UAPR) - Defense World
Ashton Thomas Private Wealth LLC Purchases Shares of 221 Moderna, Inc. (NASDAQ:MRNA) - Defense World
108 Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Purchased by Ashton Thomas Private Wealth LLC - Defense World
7 Top Gene-Editing Stocks to Buy | Investing - U.S News & World Report Money
Where are the Opportunities in (PBE) - Stock Traders Daily
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So. - MSN
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
Top Canadian Genetics Stocks of 2024 - The Motley Fool Canada
Where Are Biotech ETFs Headed After Q4 Earnings? - MSN
SPMO ETF is a good VOO, and SPY alternative with a catch - MSN
Banque Cantonale Vaudoise Makes New $358,000 Investment in Copart, Inc. (NASDAQ:CPRT) - Defense World
Commonwealth Equity Services LLC Increases Stock Holdings in Nuveen ESG Large-Cap Value ETF (BATS:NULV) - Defense World
Commonwealth Equity Services LLC Boosts Stock Holdings in iShares MSCI KLD 400 Social ETF (NYSEARCA:DSI) - Defense World
IFG Advisory LLC Acquires 3,300 Shares of The Gabelli Equity Trust Inc. (NYSE:GAB) - Defense World
IFG Advisory LLC Sells 17,771 Shares of Abrdn Asia-Pacific Income Fund Inc (NYSEAMERICAN:FAX) - Defense World
IFG Advisory LLC Makes New $214,000 Investment in Vanguard Industrials ETF (NYSEARCA:VIS) - Defense World
Invesco Biotechnology Genome Etf Stock (PBE) Financials Data
There is no financial data for Invesco Biotechnology Genome Etf (PBE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.32%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):